Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H31F3O |
Molecular Weight | 356.4654 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 4 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)C(F)(F)F
InChI
InChIKey=PLWROONZUDKYKG-DOFZRALJSA-N
InChI=1S/C21H31F3O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(25)21(22,23)24/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3/b7-6-,10-9-,13-12-,16-15-
Molecular Formula | C21H31F3O |
Molecular Weight | 356.4654 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 4 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/25971887
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25971887
Arachidonyltrifluoromethane (more known as arachidonyl trifluoromethyl ketone) is a potent and selective slow binding inhibitor of the cytosolic phospholipase A2 (cPLA2). This compound is commonly used in the study of cPLA2-related neurodegenerative diseases. It was shown, that arachidonyl trifluoromethyl ketone decreased the levels of injurious lipid mediators, reduced pain, improved functional deficits, and conferred protection against lumbar spinal canal stenosis (LSS) injury. Thus, it shows potential for preclinical evaluation in LSS.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P47712 Gene ID: 5321.0 Gene Symbol: PLA2G4A Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/8195210 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Prostacyclin production in rat aortic smooth muscle cells: role of protein kinase C, phospholipase D and cyclooxygenase-2 expression. | 2003 Nov 1 |
|
Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors. | 2004 Jul 1 |
|
Arachidonic acid signaling is involved in the mechanism of imidazoline-induced KATP channel-independent stimulation of insulin secretion. | 2007 Nov |
|
Significance of the nongenomic, inflammatory pathway in mediating the toxic action of TCDD to induce rapid and long-term cellular responses in 3T3-L1 adipocytes. | 2008 Dec 30 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25971887
in rats: arachidonyl trifluoromethyl ketone, ATK (7.5 mg/kg) was administered by oral gavage at 2 h following the cauda equina compression (CEC). ATK treatment of CEC animals reduced the phosphorylation of cPLA2 (pcPLA2) determined by Western blot, improved locomotor function evaluated by rotarod task, and reduced pain threshold evaluated by mechanical hyperalgesia method.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8195210
Arachidonyl trifluoromethyl ketone (AACOCF3) inhibited the release of AA from calcium ionophore-challenged U937 cells (IC50 = 8 microM, 2 x 10(6) cells ml-1) and from platelets (IC50 = 2 microM, 4 x 10(7) cells ml-1). AACH(OH)CF3 did not inhibit the production of AA in the ionophore-challenged cells. In addition to the release of AA, AACOCF3 also inhibited the production of 12-hydroxyeicosatetraenoic acid (12-HETE) and thromboxane B2, two of the major metabolites of AA produced by platelets
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:21:54 GMT 2023
by
admin
on
Fri Dec 15 19:21:54 GMT 2023
|
Record UNII |
00XIW1CR0F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
149301-79-1
Created by
admin on Fri Dec 15 19:21:54 GMT 2023 , Edited by admin on Fri Dec 15 19:21:54 GMT 2023
|
PRIMARY | |||
|
5280436
Created by
admin on Fri Dec 15 19:21:54 GMT 2023 , Edited by admin on Fri Dec 15 19:21:54 GMT 2023
|
PRIMARY | |||
|
2341
Created by
admin on Fri Dec 15 19:21:54 GMT 2023 , Edited by admin on Fri Dec 15 19:21:54 GMT 2023
|
PRIMARY | |||
|
C081565
Created by
admin on Fri Dec 15 19:21:54 GMT 2023 , Edited by admin on Fri Dec 15 19:21:54 GMT 2023
|
PRIMARY | |||
|
Arachidonyl trifluoromethyl ketone
Created by
admin on Fri Dec 15 19:21:54 GMT 2023 , Edited by admin on Fri Dec 15 19:21:54 GMT 2023
|
PRIMARY | |||
|
DTXSID901017144
Created by
admin on Fri Dec 15 19:21:54 GMT 2023 , Edited by admin on Fri Dec 15 19:21:54 GMT 2023
|
PRIMARY | |||
|
00XIW1CR0F
Created by
admin on Fri Dec 15 19:21:54 GMT 2023 , Edited by admin on Fri Dec 15 19:21:54 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |